Journal
JOURNAL OF IMMUNOLOGY
Volume 173, Issue 10, Pages 6234-6240Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.173.10.6234
Keywords
-
Categories
Funding
- NCI NIH HHS [P50 CA 90388, CA 87879] Funding Source: Medline
- NHLBI NIH HHS [P50 HL 67665, HL 66027] Funding Source: Medline
Ask authors/readers for more resources
Chemokines are recognized as functionally important in many pathological disorders, which has led to increased interest in mechanisms related to the regulation of chemokine receptor (CKR) expression. Known mechanisms for regulating CKR activity are changes in gene expression or posttranslational modifications. However, little is known about CKR with respect to a third regulatory mechanism, which is observed among other seven-transmembrane receptor subfamilies, the concept of differential splicing or processing of heteronuclear RNA. We now report on the discovery of a variant human CKR, CXCR3, resulting from alternative splicing via exon skipping. The observed RNA processing entails a drastically altered C-terminal protein sequence with a predicted four- or five-transmembrane domain structure, differing from all known functional CKR. However, our data indicate that that this splice variant, which we termed CXCR3-alt, despite its severe structural changes still localizes to the cell surface and mediates functional activity of CXCL11.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available